Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Just a few days from demerger. I'm looking forward to owning some shares in the new company, with a product that is working to save lives by identifying potential cancers for treatment; and may well work better than any similar diagnostic tool on the market. Should they do further testing to evidence this, then the value will rocket.
From annual report..
StemPrintER is a multi-gene signature assay intended for use in patients diagnosed with estrogen-receptor positive ER+/HER2 negative breast cancers. The Group believes this in-vitro prognostic test will be used in conjunction with clinical evaluation to identify those patients at increased risk for early and/or late metastasis.
On May 29,2020, the Company announced results from from a poster selected for discussion session at the American Society of Clinical Oncology (ASCO) Virtual Conference, demonstrating the superiority of StemPrintER stem cell based genomic prognostic tool versus the market leader, Oncotype DX, in predicting recurrence in ER+/HER2- postmenopausal breast cancer patients. A second poster describing results on prediction of distant recurrence using a next generation StemPrintER model, named SPARE, presented in a separate ASCO session, showed even more refined accuracy than standard clinicopathological markers in predicting risk of distant recurrence. The company also announced its plans to demerge StemPrintER and SPARE technology and create a separate company to advance commercialization of the technology.
There's a host of miners expanding without any production, and here we are IMO on the cusp of a breakout linked to production and refinance. It's true that like many, I would rather I was getting in now rather than earlier, but to those considering investing, DYOR and have a look through the prospects. Fundamentals are good, but there is some proving up to be done in terms of quality/quantity and board competence. Timing an investment is darn tricky isn't it. GLA.
And yes I'm averaging up with profits from elsewhere... Reflecting my confidence in prospects
Hi Gin.
Whether you're averaging up or down makes no odds really. Both make sense if you are confident the share price will rise at point of purchase. That said buying on this basis above your initial purchase can mean your chasing profit rather than a loss, and psychologically you benefit from being right about the share price direction already.. I. E. Up, which will provide more confidence in your interpretation of the company and its SP.
Thanks Chester, your input very much welcome as always. And those late to the party, do have a go, I'm sure the insight is valued to new and old investors alike,
Hopefully we can revise our estimates upwards come January!
Chester, do we need to be concerned about this proceeding to "I know where you all live"
:-)
I anticipated this being a lot higher when I bought in in April. Given that and Covid causing disruption 0.70 for me...Still a 1 bagger on current SP.
GLA
Thinking of investing. How do you see the RNS?
Branson... Laughed at that thanks
I disagree that this is a risky share at these levels. For new investors this is a great opportunity. With the major expansion underway, funded by the placement, and excellent products which they couldn't previously make enough quantity of, this should be making major strides.. I doubt there are many traders in this share at present but this week with interim results and the q and a should be significant. I too see this as a longterm superb prospect from these levels. I await details of sales and demand with interest, acknowledging the c19 factor.
Another pile of tiny trades today. A pattern repeated a few days this week.
Some days none at all, other days there are tens of them. I'm not convinced these are coincidental (as mentioned by others); but still none the wiser as to their meaning. Anyone confess to making those trades? or willing to interpret?
Hi Gin,
Given they are outsourcing some of the tasks, they may need less space. That said, you may also want a little bit of expansion room in a headquarters. I suspect the cost saving is as much to do with recession and a renter's market as size of premises or location. That said, it would be nice to have such details, rather than guessing. Their twitter page was last updated in March. The website is skant. Linkedin has some 'nice' clinical case studies though.
I will happily join a £1 party - it may come sooner than you think.
Looking forward to trading update; with fingers crossed.
Chester. I spotted the trade this morning (I don't have the specific time).
Noteworthy because I recall it was at 0.31.
MRK
some platforms do not charge per trade, for various reasons (e.g. over a certain volume of trades/subscription based)
https://www.hardmanandco.com/wp-content/uploads/2020/07/Hardman-Co-Monthly-August-2020.pdf
p37. it's a one pager broker summary of the business, with most of the info in Sandhopper's post below. All in all a positive read. And reiterates that the SP should pick up once the funded expansion and increased supply/sales takes off. It notes Covid-19 will have dimmed some of the initial increased sales potential due to deferred operations. IMO this is already reflected in the deflated SP. So, a very good time to buy if you can hold for a while, as price may be at low, and may rise prior to September interim results, but DYOR etc.
IVANS - no broker target price estimate therein.
To be fair concern over placing was fair. That said, a really good interview today providing a lot of reassurance. AP clarified a lot of the issues raised on this bb.. Re placing, assays, jorc, grades, production {underground and overground), financing... All positive. AP was clearly excited re the gold and silver results with current prices. He confirmed there would be further RNS next week (with further positive news). I have always considered production at BP the key success determinant.. And with that being delivered its looking up from here imp.